Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

November 30, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Methoxsalen

PROCEDURE

Extracorporeal Photopheresis

Trial Locations (32)

Unknown

Carroll County Arthritis and Osteoporosis Center, Westminister

Clinical Pharmacology Study Group, Worchester

Morristown Memorial Hospital, Morristown

AAIR Research Center, Rochester

Carolina Arthritis Associates, Wilmington

Rheumatic Disease Associates, Willow Grove

Rheumatology Associates, Providence

UT Southwestern Medical Center, Dallas

Arthritis and Osteoporosis Center of South Texas, San Antonio

Benaroya Research Institute at Virginia Mason, Seattle

Royal Brisbane Hospital, Herston

General Hospital of Vienna, Vienna

Hospital Brugmann, Brussels

Limburgs Universitair Centrum, Diepenbeek

Rebecca MacDonald Centre for Arthritis, Toronto

CHRU de Lille, Lille

Hopital Edouard Herriot, Lyon

Franz von Prummer Klinik, Bad Brückenau

University of Charite Clinic for Rheumatology and Immunology, Berlin

Klinikum der Universitat zu Koln, Cologne

Medizinische Klinik III, Erlangen

Abt. Rheumatologie und Klinische Immunologie, Hamburg

Westfalische wilhelms-universitat Munster, Münster

Medizinische Klinik des Evangelischen Kranken, Oldenburg

Universita degli Studi di Firenze, Florence

Universita de Genova - Ospedale S. Martino, Genova

University of Siena-Italy, Siena

"OPD- Hospital Civil Dr. Jaun I. Menchaca", Guadalajara

Reumatologicka ambulancia, Polinika, Bratislava

South African National Blood Service, Bloemfontein

Christian Barnard Mermorial Hospital, Cape Town

D6 Rheumatology Clinic and E5 Hematology Unit, Cape Town

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY